Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-021008
Filing Date
2019-03-22
Accepted
2019-03-22 16:47:00
Documents
1
Period of Report
2019-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4026
  Complete submission text file 0001209191-19-021008.txt   5551
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DR, SUITE 101 SAN DIEGO CA 92121
Business Address
Oien Jessica (Reporting) CIK: 0001760712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 19700415